The visually impaired patient

American Family Physician

Volumn 77, Issue 10, 2008, Pages

  Rosenberg, Eric A ^a,c   Sperazza, Laura C ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Jewish Guild for the Blind   (United States)

^c Cornell Medical Associates West Side ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; ENDOTHELIAL CELL GROWTH FACTOR; GLUCOSE; MIOTIC AGENT; PROSTAGLANDIN; ZINC;

BLINDNESS; CATARACT; COLOR VISION; COMORBIDITY; CONTRAST SENSITIVITY; DIABETIC RETINOPATHY; ENVIRONMENT; FILTER; GLARE; GLAUCOMA; HANDHELD MAGNIFIER; HEALTH; HUMAN; ILLUMINATION; INDEPENDENCE; INTERVENTION STUDY; LASER COAGULATION; LIFESTYLE; LOW LEVEL LASER THERAPY; OPTICAL INSTRUMENTATION; PHYSICIAN; PRIMARY MEDICAL CARE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; REVIEW; SCREENING; SPECTACLES; TELEMICROSCOPE; UNITED STATES; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; AGED; ATTITUDE TO HEALTH; EYE DISEASE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATIENT; PATIENT EDUCATION; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; RETINA MACULA DEGENERATION; STATISTICS; VISUAL DISORDER;

AGED; CATARACT; DIABETIC RETINOPATHY; EYE DISEASES; FEMALE; GLAUCOMA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; UNITED STATES; VISION DISORDERS; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 45549106527     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Burack-Weiss A. Psychological aspects of aging and vision loss. In: Faye E, Stuen CS, eds. The Aging Eye and Low Vision: A Study Guide for Physicians. New York, NY: Lighthouse; 1992:29-34.
2. National Eye Institute. Vision loss from eye diseases will increase as Americans age [press release]. April 12, 2004. http://www.nei.nih.gov/news/ pressreleases/041204.asp. Accessed August 3, 2007.
3. Solomon R, Donnenfeld ED. Recent advances and future frontiers in treating age-related cataracts [published correction appears in JAMA. 2003;290(22):2943]. JAMA. 2003;290(2):248-251.
4. Taylor HR. Fred Hollows lecture. Eye care for the community. Clin Experiment Ophthalmol. 2002;30(3):151-154.
5. The Eye Diseases Prevalence Research Group. Statistics and data. Citations and abstracts from April 2004 Archives of Ophthalmology. Causes and prevalence of visual impairment among adults in the United States. http://www.nei.nih.gov/eyedata/pbd1.asp. Accessed January 25, 2008.
6. Kupfer C. The National Eye Institute's low vision education program: improving quality of life [editorial]. Ophthalmology. 2000;107(2):229-230. (Pubitemid 30191395)
7. Carter TL. Age-related vision changes: a primary care guide. Geriatrics. 1994;49(9):37-42,45. (Pubitemid 24301895)
8. American Academy of Ophthalmology. Policy Statement. Frequency of Ocular Examinations. http://www.aao.org/about /policy/upload/2006-Frequency.pdf. Accessed January 25, 2008.
9. Lord SR, Menz HB. Visual contributions to postural stability in older adults. Gerontology. 2000;46(6):306-310. (Pubitemid 30816478)
10. Fletcher DC. Low vision: the physician's role in rehabilitation and referral. Geriatrics. 1994;49(5):50-53. (Pubitemid 24136890)
11. Castor TD, Carter TL. Low vision: physician screening helps to improve patient function. Geriatrics. 1995;50(12):51-52,55-57. (Pubitemid 26006681)
12. de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355(14):1474-1485. (Pubitemid 44511562)
13. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436. (Pubitemid 32963246)
14. U.S. Preventive Services Task Force. Screening for glaucoma. http://www.ahrq.gov/clinic/uspstf/uspsglau.htm. Accessed August 3, 2007.
15. Melton R, Thomas R. Glaucoma. In: 2006 Clinical Guide to Opthalmic Drugs. Rev Optometry. 2006;(suppl): 12A-18A. http://www.revoptom.com/drugguide/pdf/ drugguide2006.pdf. Accessed January 25, 2008.
16. Robinson B, Acorn CJ, Millar CC, Lyle WM. The prevalence of selected ocular diseases and conditions. Optom Vis Sci. 1997;74(2):79-91. (Pubitemid 27147881)
17. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005;365(9459):599-609. (Pubitemid 40247918)
18. Bowyer NK. A primary care team approach to the prevention of ocular complications of diabetes: a program review. J Am Optom Assoc. 1997;68(4):233-242.
19. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published correction appears in Lancet. 1999;354(9178):602]. Lancet. 1998;352(9131):837- 853.
20. American Diabetes Association. Standards of medical care in diabetes - 2006 [published correction appears in Diabetes Care. 2006;29(5):1192]. Diabetes Care. 2006;(29 suppl 1):S4-S42.
21. American Academy of Ophthalmology. Diabetic retinopathy. Preferred practice pattern guideline. http://www.aao.org/education/guidelines/ppp/dr-new. cfm. Accessed August 3, 2007.
22. Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci. 2001;78(5):335-342. (Pubitemid 32493436)